We are thrilled to announce that KZ Organics has been officially approved for the Seed Enterprise Investment Scheme (SEIS) and the Enterprise Investment Scheme (EIS). This milestone not only signifies our commitment to innovation and growth but also offers an exceptional opportunity for our investors.
What Does SEIS/EIS Approval Mean?
The UK government introduced SEIS and EIS to encourage investment in early-stage companies by offering attractive tax reliefs to individual investors. Our acceptance into these schemes underscores our dedication to pioneering solutions in the skincare industry, particularly for those affected by parosmia.
Benefits for Our Investors
Investing in KZ Organics through SEIS or EIS provides a range of financial incentives:
Income Tax Relief: Under SEIS, investors can claim up to 50% income tax relief on investments up to £200,000 per tax year. For EIS, the relief is 30% on investments up to £1 million, extendable to £2 million if at least £1 million is invested in knowledge-intensive companies.
Capital Gains Tax (CGT) Exemption: Any gains realized from the sale of shares after a three-year holding period are exempt from CGT, provided the initial income tax relief was claimed and not withdrawn.
Loss Relief: Should the investment not perform as expected, investors can offset losses against their income or capital gains tax liabilities, reducing the financial impact.
Inheritance Tax Relief: Investments held for at least two years may qualify for 100% relief from inheritance tax, as they are considered business property.
Join Us on Our Journey
We are currently raising £500,000 to accelerate our mission of delivering innovative, sustainable skincare solutions. By investing in KZ Organics, you are not only supporting a brand dedicated to enhancing the well-being of parosmia sufferers but also benefiting from substantial tax reliefs.
To express your interest and learn more about this opportunity, please visit our SEIS page:
Thank you for your continued support as we embark on this exciting new chapter.
Note: Investing in early-stage companies carries inherent risks. Potential investors are advised to consult with a financial advisor to fully understand the benefits and risks associated with SEIS and EIS investments.
Comments